Van Eck Associates Corp Acadia Pharmaceuticals Inc Transaction History

Van Eck Associates Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$22.47 - $32.33 $4.5 Million - $6.47 Million	-200,190 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$26.84 - $39.14 $2.69 Million - $3.92 Million	-100,054 Reduced 33.32%	200,190 $6.03 Million
Q3 2017 Nov 09, 2017	BUY	$29.49 - $38.37 $957,540 - $1.25 Million	32,470 Added 12.13%	300,244 $11.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	267,774	267,774 $7.47 Million

316

164M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.